Wali F A, Suer A H, Greenidge E
Pharmacol Res Commun. 1986 Dec;18(12):1123-38. doi: 10.1016/0031-6989(86)90028-7.
Verapamil (0.02-2 microM), diltiazem (0.22-8.14 microM) and nifedipine (0.29-8.96 microM) produced concentration-dependent relaxation of human isolated saphenous vein. Based on the EC50 values of the calcium entry blockers, verapamil (relative potency = 1) was 7 and 5 times as potent as nifedipine and diltiazem, respectively, in producing relaxation of the human saphenous vein. In addition, verapamil, diltiazem and nifedipine inhibited the vascular responses (i.e. contractions) produced by noradrenaline (0.03-36 microM), acetylcholine (0.05-55 microM) and 5-hydroxytryptamine (0.02-25 microM) and to KCl (10-100 mM). It was concluded that verapamil, diltiazem and nifedipine relaxed the human isolated saphenous vein, verapamil being more potent than diltiazem or nifedipine, and modified the vascular response to vasoconstrictor agents, e.g. noradrenaline, acetylcholine, 5-hydroxytryptamine and KCl. Thus verapamil, diltiazem and nifedipine may inhibit calcium influx through both potential and receptor-operated calcium ion channels.
维拉帕米(0.02 - 2微摩尔)、地尔硫䓬(0.22 - 8.14微摩尔)和硝苯地平(0.29 - 8.96微摩尔)可引起人离体大隐静脉浓度依赖性舒张。根据钙通道阻滞剂的半数有效浓度(EC50)值,在使人的大隐静脉舒张方面,维拉帕米(相对效能 = 1)分别比硝苯地平和地尔硫䓬强7倍和5倍。此外,维拉帕米、地尔硫䓬和硝苯地平可抑制去甲肾上腺素(0.03 - 36微摩尔)、乙酰胆碱(0.05 - 55微摩尔)、5 - 羟色胺(0.02 - 25微摩尔)以及氯化钾(10 - 100毫摩尔)所引起的血管反应(即收缩)。得出的结论是,维拉帕米、地尔硫䓬和硝苯地平可使人大隐静脉舒张,维拉帕米比地尔硫䓬或硝苯地平更有效,并且可改变血管对血管收缩剂如去甲肾上腺素、乙酰胆碱、5 - 羟色胺和氯化钾的反应。因此,维拉帕米、地尔硫䓬和硝苯地平可能通过电压门控性和受体操纵性钙离子通道抑制钙内流。